eli lilly glp-1 sales performance GLP 1 Drugs Availability Booms ๐ Leading The GLP-1 Revolution
Description
Non-diabetic users have increased from 8% of new users in 2020 to 34% in 2023
Dinner: Baked salmon with quinoa and steamed broccoli
GLP-1 Therapy NYC - Dr
Researchers found that GLP-1 signaling directly correlated with the decrease of pro-inflammatory cytokine production, which includes tumor necrosis factor-alpha (TNF-) and interleukin-6 (IL-6)
A separate 2025 meta-analysis, including more than 84,000 GLP-1 users across 34 studies, similarly concluded that those taking the drugs were 3.4 times more likely to experience hair loss compared to those who were not
10.1038/s41556-024-01549-x Nat Cell Biol
